Logo

EXPO

Exponent, Inc.

EXPO

Exponent, Inc. • NASDAQ
$72.30 ▼ -0.37% (-0.27)
Market Cap $3.61 B
52w High $99.72
52w Low $63.81
Dividend Yield 1.18%
P/E 35.62
Volume 245.88K
Outstanding Shares 49.89M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $147.12M ▲ $7.654M ▲ $28.044M ▲ 19.062% ▲ $0.55 ▲ $41.149M ▲
Q2-2025 $141.962M ▼ $6.145M ▼ $26.553M ▼ 18.704% ▲ $0.52 $34.323M ▼
Q1-2025 $145.507M ▲ $93.005M ▲ $26.65M ▲ 18.315% ▲ $0.52 ▲ $40.252M ▲
Q4-2024 $136.766M ▲ $5.742M ▼ $23.589M ▼ 17.248% ▼ $0.46 ▼ $33.818M ▼
Q3-2024 $136.279M $98.457M $26.044M 19.111% $0.51 $38.326M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $207.38M ▼ $761.449M ▲ $358.588M ▲ $402.861M ▼
Q2-2025 $231.801M ▼ $759.43M ▼ $331.654M ▲ $427.776M ▼
Q1-2025 $245.113M ▼ $763.239M ▼ $321.831M ▼ $441.408M ▲
Q4-2024 $258.901M ▲ $777.27M ▲ $356.202M ▲ $421.068M ▲
Q3-2024 $219.708M $744.065M $333.791M $410.274M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $28.044M ▲ $32.652M ▼ $-2.675M ▼ $-54.507M ▼ $-24.421M ▼ $29.977M ▼
Q2-2025 $26.553M ▼ $36.222M ▲ $-2.274M ▼ $-47.468M ▼ $-13.312M ▲ $33.948M ▲
Q1-2025 $26.65M ▲ $7.274M ▼ $-1.754M ▲ $-20.049M ▼ $-13.788M ▼ $5.52M ▼
Q4-2024 $23.589M ▼ $56.052M ▲ $-2.597M ▼ $-12.32M ▲ $39.193M ▲ $53.455M ▲
Q3-2024 $26.044M $29.714M $-1.714M $-12.959M $16.446M $28M

Revenue by Products

Product Q3-2024Q4-2024Q1-2025Q2-2025
Engineering And Other Scientific
Engineering And Other Scientific
 $120.00M ▲$110.00M ▼$120.00M ▲$120.00M ▲
Environmental And Health
Environmental And Health
 $20.00M ▲$20.00M ▲$20.00M ▲$20.00M ▲

Five-Year Company Overview

Income Statement

Income Statement Exponent shows a pattern of steady, measured growth rather than big swings. Revenue has increased consistently over the past five years, and profits have generally kept pace. Margins are healthy for a consulting business, suggesting good pricing power and efficient use of staff and facilities. Earnings per share have trended upward, with only small bumps along the way, indicating a mature, well-managed firm that is adding value over time rather than chasing risky growth. Overall, the income statement reflects a stable, profitable, and fairly predictable business model.

Balance Sheet

Balance Sheet The balance sheet looks conservative and resilient. The company holds a solid cash cushion relative to its size, and debt levels remain low, even though borrowings have crept up slightly in the most recent year. Equity has grown steadily, which signals that retained profits are strengthening the company’s financial foundation. This mix of strong cash, modest leverage, and growing equity suggests Exponent is well-positioned to handle downturns and to fund its own growth without relying heavily on lenders.

Cash Flow

Cash Flow The limited cash flow data available points to a business that reliably converts its profits into cash. Operating cash flow is comfortably positive, and free cash flow remains strong after relatively modest spending on facilities and equipment. That means the company is not capital intensive and can generate excess cash even while investing in its operations. The main caveat is that the disclosed cash flow history is spotty, so while the picture looks favorable, it is based on only a few reported years.

Competitive Edge

Competitive Edge Exponent occupies a specialized, high‑reputation niche in engineering and scientific consulting. Its brand is closely associated with high‑stakes investigations and complex failure analysis, which has been built up over decades of work on widely known industrial and legal cases. The firm’s deep bench of highly educated experts across many disciplines, plus long-standing relationships with repeat clients, creates meaningful barriers for new entrants. High switching costs, strong credibility in courtrooms and regulatory settings, and the ability to cross-sell many specialized services give Exponent a durable competitive edge compared with more generalist consulting firms.

Innovation and R&D

Innovation and R&D Innovation at Exponent is less about classic product R&D and more about continually advancing its scientific methods, tools, and data capabilities. The company leans on proprietary databases, specialized testing protocols, and a large testing campus to run complex simulations that few competitors can match. It is also pushing into newer areas like AI safety, digital health, wearable technology, and ESG-related advisory work, all built on its analytical and human-factors expertise. This ongoing expansion into emerging technical fields suggests that Exponent is actively refreshing its service portfolio to stay relevant as technologies and regulatory needs evolve.

Summary

Exponent presents as a high‑quality, specialized consulting firm with a long track record of steady growth, solid profitability, and conservative finances. Its balance sheet strength and cash generation support a business that can invest in people, technology, and facilities without taking on heavy risk. The real backbone of the company is its reputation, expert workforce, and accumulated know‑how, which together form a strong competitive moat. The main opportunities appear to be in scaling proactive advisory services and newer domains like AI safety and digital health, while the main risks relate to maintaining its talent base and reputation in a market where credibility is everything.

NEWS

October 30, 2025 · 4:05 PM UTC

Exponent Reports Third Quarter of Fiscal Year 2025 Financial Results

Read more

October 15, 2025 · 4:40 PM UTC

VINFAST TO JOIN ELECTRIFY EXPO NEW YORK INDUSTRY DAY WITH PANEL AND VEHICLE SHOWCASE

Read more

October 9, 2025 · 4:05 PM UTC

Exponent to Announce Third Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on October 30, 2025

Read more